Fxr 450 is primarily utilized in the field of medical research, particularly in studies focused on metabolic disorders. It acts as a potent agonist for the farnesoid X receptor (FXR), a nuclear receptor involved in regulating bile acid, lipid, and glucose metabolism. Researchers employ Fxr 450 to investigate its potential therapeutic effects in conditions such as non-alcoholic fatty liver disease (NAFLD), cholestasis, and diabetes. By modulating FXR activity, it helps in understanding the pathways that control metabolic homeostasis and inflammation. Additionally, Fxr 450 is explored for its role in improving insulin sensitivity and reducing hepatic steatosis, making it a promising candidate for developing treatments for metabolic syndrome and related disorders.